UNSPSC 51433404: Quinaprilat

This classification denotes an ace inhibitor with the molecular formula C23H26N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34SSX5LDE5, chemically known as 3-isoquinolinecarboxylic acid, 2-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s)- but generally known as quinaprilat, which bears US NIH Compound Identifier 107994. European Medicines Agency schedules Quinaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10202MIG.

UNSPSC 51433404 Quinaprilat is a Commodity code that encompasses individual pharmaceutical active ingredients and formulations procured by state and local health systems, emergency services, and public health agencies. In practice, state and local buyers use this code and its parent classifications to tag solicitations for specific medications and drug formulations required for clinical care, emergency response, and public health operations. The code captures both branded and generic pharmaceutical products supplied as finished goods—vials, injections, tablets, and other dosage forms—rather than raw chemical inputs or bulk active pharmaceutical ingredients. Issuing bodies under this code include municipal fire and rescue departments, county health departments, state health agencies, and public hospital systems, typically procuring through sealed-bid IFBs and RFQs to secure firm pricing and reliable supply chains with contractual quality and expiration-date guarantees.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026. The solicitation requested four specific medication line items—Labetalol HCI 100mg vials, Epinephrine 1:10,000 injections, Adenosine 6mg vials, and Diltiazem 25mg vials—with a total estimated contract value of $40,000.00 and a one-year initial term plus optional renewals. The bid included a 5 percent SLBE (Small Local Business Enterprise) discount not to exceed $10,000. Vendors were required to deliver medications within ten calendar days of order receipt, maintain a minimum nine-month expiration window from acceptance, and comply with OSHA Hazard Communication Standards and WCAG 2.2 accessibility documentation standards.